| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PGEN | Common Stock | Options Exercise | +26,102 | +9.5% | 300,754 | 18 May 2021 | Direct | F1 | ||
| transaction | PGEN | Common Stock | Sale | $59,049 | -8,907 | -3% | $6.63 | 291,847 | 19 May 2021 | Direct | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PGEN | Restricted Stock Units | Options Exercise | $0 | -26,102 | -100% | $0.000000* | 0 | 18 May 2021 | Common Stock | 26,102 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | Each restricted stock unit ('RSU") represents a contingent right to receive one share of Precigen common stock. |
| F2 | This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of RSUs. |
| F3 | The RSUs were granted on March 25, 2021 and have vested in full. |